Načítá se...
USE OF FDA-APPROVED ALZHEIMER’S DISEASE MEDICATIONS AMONG NON-INSTITUTIONALIZED U.S. ADULTS AGE 60 YEARS AND OLDER
This study examined the use of Alzheimer’s Disease medications (ADMs) among non-institutionalized U.S. adults aged 60 years and older. It described the characteristics of ADM users, compared them to adults who were not currently using ADMs, and examined how demographic characteristics, living arrang...
Uloženo v:
| Vydáno v: | Innov Aging |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6840710/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igz038.1737 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|